Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 1.00 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.61 |
| ▸ | HRH1 | P35367 | 1/20 | 0.60 |
| ▸ | IDO1 | P14902 | 2/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.58 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.56 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29350784 | 1.00 | TAAR1 (1.00) | TAAR1AOC3HRH1IDO1ADRA1A | |
| Iodide SCHEMBL28805523 | 0.98 | TAAR1 (0.96) | TAAR1AOC3HRH1IDO1ADRA1A | |
| Hydrochloric Acid SCHEMBL11152248 | 0.98 | TAAR1 (0.96) | TAAR1AOC3HRH1IDO1ADRA1A | |
| SCHEMBL8349999 | 0.89 | TAAR1 (0.79) | TAAR1AOC3HRH1IDO1ADRA1A | |
| SCHEMBL31689750 | 0.88 | TAAR1 (0.78) | TAAR1AOC3IDO1SIGMAR1 | |
| SCHEMBL4860531 | 0.88 | TAAR1 (0.78) | TAAR1AOC3IDO1SIGMAR1 | |
| SCHEMBL28858018 | 0.86 | TAAR1 (0.75) | TAAR1AOC3IDO1SIGMAR1 | |
| SCHEMBL7056767 | 0.86 | TAAR1 (0.75) | TAAR1AOC3IDO1SIGMAR1 | |
| Hydrochloric Acid SCHEMBL1026023 | 0.86 | TAAR1 (0.75) | TAAR1AOC3IDO1SIGMAR1 | |
| SCHEMBL29263690 | 0.84 | TAAR1 (0.72) | TAAR1AOC3IDO1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1332 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250145472-A1 | METHOD FOR GENERATING CARBON DIOXIDE | KOBE GAKUIN EDUCATIONAL FOUNDATION (JP) | 2025-05-08 | — | — | US | claimed |
| EP-4480568-A1 | METHOD FOR GENERATING CARBON DIOXIDE | Kobe Gakuin Educational Foundation (JP) | 2024-12-25 | — | — | EP | claimed |
| US-20240199542-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-06-20 | — | — | US | claimed |
| EP-4313943-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | Bayer Aktiengesellschaft (DE) | 2024-02-07 | — | — | EP | claimed |
| CN-114470237-B | Virus-like structural gene vector, drug delivery system, preparation method and application thereof | 中国科学院长春应用化学研究所 | 2023-12-19 | — | — | CN | claimed |
| WO-2023153506-A1 | METHOD FOR GENERATING CARBON DIOXIDE | 学校法人神戸学院 | 2023-08-17 | — | — | WO | claimed |
| EP-3688131-B1 | COMPOSITIONS AND METHODS FOR PREVENTING COLLAPSE OF HIGH ASPECT RATIO STRUCTURES DURING DRYING | VERSUM MAT US LLC (US) | 2023-08-09 | — | — | EP | claimed |
| WO-2022200208-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2022-09-29 | — | — | WO | claimed |
| CN-109563085-B | Piperidine CXCR7 receptor modulators | 爱杜西亚药品有限公司 | 2022-08-09 | — | — | CN | claimed |
| EP-3490986-B1 | PIPERIDINE CXCR7 RECEPTOR MODULATORS | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-11-24 | — | — | EP | claimed |
| EP-1011656-A2 | A METHOD FOR TREATING TENSION-TYPE HEADACHE | Head Explorer ApS (DK) | 2000-06-28 | — | — | EP | claimed |
| EP-0674232-B1 | Recording sheets | XEROX CORP (US) | 2000-05-31 | — | — | EP | claimed |
| WO-2000006525-A9 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | HARVARD COLLEGE (US) | 2000-04-20 | — | — | WO | claimed |
| WO-2000006525-A2 | SYNTHESIS OF COMBINATORIAL LIBRARIES OF COMPOUNDS REMINISCENT OF NATURAL PRODUCTS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-02-10 | — | — | WO | claimed |
| WO-1998019674-A2 | A METHOD FOR TREATING TENSION-TYPE HEADACHE | HEAD EXPLORER APS (DK) | 1998-05-14 | — | — | WO | claimed |
| US-5663022-A | Recording sheets | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| EP-0674232-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| EP-0054132-B1 | PYRIMIDONES, THEIR PREPARATION AND MEDICINES CONTAINING THEM | Dr. Karl Thomae GmbH (DE) | 1984-10-10 | — | — | EP | claimed |
| US-4419367-A | METHYLTHIO-OR METHOXYPHENETHYLAMINE, SEX | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM (IL) | 1983-12-06 | — | — | US | claimed |
| US-4379788-A | HYPOTENSIVES, ANTIARRHYTHMIA, B-BLOCKERS | DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1983-04-12 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240199542-A1 | SUBSTITUTED PYRROLIDIN-2-ONES, SALTS THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | HPD, DDT, PPOX | TAAR1 3744/4885AOC3 954/4885HRH1 3560/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.